Tamoxifen versus toremifene in the adjuvant treatment of breast cancer

Eur J Cancer. 2002 Nov:38 Suppl 6:S37-8. doi: 10.1016/s0959-8049(02)00279-4.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Neoplasm Recurrence, Local
  • Prospective Studies
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Tamoxifen / adverse effects
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Tamoxifen